Position in ICLR
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,449,609
+$560,124 QoQ
Shares Held
8,345
+3.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#191
of 424 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NewEdge Wealth, LLC holds $44,743,682 across 11 Diagnostics & Research names. ICLR ranks #5 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
51,943 | $27,508,493 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
10,697 | $5,363,047 | |
| 3 | DHR |
Danaher Corp /De/
|
23,171 | $4,413,612 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
5,843 | $3,075,988 | |
| 5 | ICLR |
Icon PLC
This page
|
8,345 | $1,449,609 | |
| 6 | NTRA |
Natera, Inc.
|
4,928 | $1,337,705 | |
| 7 | A |
Agilent Technologies, Inc.
|
5,030 | $668,134 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,091 | $247,427 |
All Filings in ICLR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,449,609 | 8,345 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $889,485 | 8,038 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $805,230 | 4,419 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $683,725 | 3,907 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $442,604 | 3,043 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $236,236 | 1,350 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $222,921 | 1,063 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||